Results 1 to 10 of about 142,166 (291)

Solitary pulmonary metastasis after meningioma surgery of the head: a case report [PDF]

open access: goldSurgical Case Reports, 2022
Background Meningioma is the most common type of benign primary brain tumor that is rarely associated with distant metastasis. No established treatment strategy for metastatic meningiomas exists to date.
Takahiro Utsumi   +7 more
doaj   +2 more sources

Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions

open access: yesBiomedicines, 2021
Meningiomas are the most common intracranial tumor, making up more than a third of all primary central nervous system (CNS) tumors. They are mostly benign tumors that can be observed or preferentially treated with gross total resection that provides good
Christian T. Ogasawara   +2 more
exaly   +2 more sources

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas

open access: yesCNS Oncology, 2021
Meningiomas are the most common primary intracranial tumors. The majority of meningiomas are benign, but they can present different grades of dedifferentiation from grade I to grade III (anaplastic/malignant) that are associated with different outcomes ...
Enrico Franceschi   +2 more
exaly   +2 more sources

Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma

open access: yesNature Communications, 2020
Meningiomas are the most common primary intracranial tumors, but the molecular drivers of meningioma tumorigenesis are poorly understood. We hypothesized that investigating intratumor heterogeneity in meningiomas would elucidate biologic drivers and ...
Stephen T Magill   +2 more
exaly   +2 more sources

Cyclic cytokines mediated the effect of immune cells on meningioma: a two-step, mediation mendelian randomization study [PDF]

open access: yesBMC Cancer
Background Meningioma is a common central nervous system tumor that poses serious health hazards and increases with age. However, the role of immune cells in meningioma remains incompletely understood. Methods Data from genome-wide association studies on
Mingsheng Huang   +4 more
doaj   +2 more sources

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma

open access: yesFrontiers in Oncology, 2020
Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled receptor and can be activated by somatostatin or its synthetic analogs.
Wei Wu   +7 more
doaj   +2 more sources

Epidemiology and etiology of meningioma [PDF]

open access: yesJournal of Neuro-Oncology, 2010
Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrations, their intracranial location often leads to serious and potentially lethal consequences.
Joseph L Wiemels, Elizabeth B Claus
exaly   +6 more sources

Identification of SLC7A1 as a potential therapeutic target for high-grade meningioma [PDF]

open access: yesCell Death Discovery
High-grade meningioma remains a therapeutic challenge. The first-line guideline drugs for high-grade meningioma are still lacking, highlighting the urgent need to uncover new therapeutic targets.
Lairong Song   +7 more
doaj   +2 more sources

Gut Microbiota Influences Meningioma Pathogenesis via Circulating Metabolites: A Two‐Sample Mendelian Randomization Study [PDF]

open access: yesBrain and Behavior
Background Meningiomas are common solitary intracranial tumors without any apparent risk factors. In light of the growing interest in gut microbiome–brain tumor interactions, this investigation sought to explore potential links between intestinal ...
Xuan Chen   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy